Jing Wei Luo

Associate | London

Client services contact Pam Taaffe


Track record

$4.2bn merger with special purpose

$4.2bn merger with special purpose acquisition company Alkuri Global, which saw Babylon trade on the NYSE as BBLN in 2021

Issuance of $200m ESG-linked notes

Issuance of $200m ESG-linked notes to AlbaCore Capital Group and its related entities in 2021, and additional issuance of $100m notes in 2022

Up-to-$550m Series C fundraise in

Up-to-$550m Series C fundraise in 2019, Europe's then-largest healthtech funding round